Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.69 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | APEX1 | P27695 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | PLG | P00747 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL718223 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL1562267 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL112966 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL12200709 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9586892 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL31616810 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL14097216 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL1562176 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| SCHEMBL9331676 | 1.00 | TSHR (0.69) | TSHRPOLBAPEX1HTTTDP1 | |
| Hydrochloric Acid SCHEMBL11438451 | 0.98 | TSHR (0.67) | TSHRPOLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250009416-A1 | COMBINATION TUMOR TREATMENT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-01-09 | — | — | US | claimed |
| EP-4121006-A1 | COMBINATION TUMOR TREATMENT | Boston Scientific Scimed Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| CN-115427018-A | Combination therapy for tumors | 波士顿科学国际有限公司 | 2022-12-02 | — | — | CN | claimed |
| US-11382929-B2 | Compositions and methods to treat disease | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2022-07-12 | — | — | US | claimed |
| WO-2021188630-A1 | COMBINATION TUMOR TREATMENT | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2021-09-23 | — | — | WO | claimed |
| US-20200405746-A1 | COMPOSITIONS AND METHODS TO TREAT DISEASE | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2020-12-31 | — | — | US | claimed |
| US-20080004402-A1 | Polymeric product for film formation | BORBELY JANOS | 2008-01-03 | — | — | US | claimed |
| EP-1201720-B1 | Printing fluid additives promoting overcoat adhesion | HEWLETT PACKARD CO (US) | 2004-09-15 | — | — | EP | claimed |
| US-6610412-B2 | Clear protective thermal transfer overcoating and acrylic polymer compatibilizer; computer prints | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2003-08-26 | — | — | US | claimed |
| US-20030119973-A1 | Printing fluid additives promoting overcoat adhesion | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2003-06-26 | — | — | US | claimed |
| US-6417249-B1 | INK JET PRINTING INK FOR COLOR VEHICLES, CORE/SHELL BINDERS, SMUDGE PROOF | HEWLETT-PACKARD COMPANY | 2002-07-09 | — | — | US | claimed |
| EP-1201720-A1 | Printing fluid additives promoting overcoat adhesion | Hewlett-Packard Company (US) | 2002-05-02 | — | — | EP | claimed |
| US-6248805-B1 | THERMAL INK JET PRNTING | HEWLETT-PACKARD COMPANY | 2001-06-19 | — | — | US | claimed |
| US-6165988-A | Medicament in particulate form | Noe, Christian (AT) | 2000-12-26 | — | — | US | claimed |
| US-6057384-A | VEHICLE AND COLORANT ASSOCIATED WITH A PRIMER CORE/SHELL POLYMER; DURABLR SMEAR-FAST FILM | HEWLETT-PACKARD COMPANY (US) | 2000-05-02 | — | — | US | claimed |
| US-5990202-A | DURABLE, SMEAR-FAST INK FILMS COMPRISING DUAL ENCAPSULATED COLORANT; A PRIMER CORE/SHELL POLYMER COATING A COLORANT (ADHESION) AND AN EXTERIOR CORE/SHELL POLYMER COATING FOR DURABILITY | HEWLETT-PACKARD COMPANY (US) | 1999-11-23 | — | — | US | claimed |
| US-5213934-A | Core of colorant and binder grafted to polymeric shell | XEROX CORPORATION (US) | 1993-05-25 | — | — | US | claimed |
| US-12504686-B2 | Black light-shielding photosensitive resin composition, black matrix, black light-shielding film, frame and filling material for splicing area | ECHEM SOLUTIONS CORP. (TW) | 2025-12-23 | — | — | US | disclosed |
| US-5213934-A | Core of colorant and binder grafted to polymeric shell | XEROX CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| US-4968559-A | RELEASING | BANDO CHEMICAL INDUSTRIES. LTD. (JP) | 1990-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11382929-B2 | Compositions and methods to treat disease | SGMS1, SGMS2, LIPA | TSHR 4631/4885POLB 2201/4885APEX1 639/4885 |
| US-20200405746-A1 | COMPOSITIONS AND METHODS TO TREAT DISEASE | SGMS1, SGMS2, LIPA | TSHR 4631/4885POLB 2201/4885APEX1 639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.